* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Information Packet
Hygiene hypothesis wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Adaptive immune system wikipedia , lookup
DNA vaccination wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Innate immune system wikipedia , lookup
Stanford iGEM: Information Session Packet THANKS FOR YOUR INTEREST IN STANFORD IGEM! PLEASE FORWARD YOUR QUESTIONS TO [email protected] OR ASK NGHI NGUYEN/ARIANE TOM (EXECUTIVE DIRECTORS). REMEMBER, THE APPLICATION IS DUE DECEMBER 1, 2008 BY MIDNIGHT, AND CAN BE FOUND HERE: HTTP://WWW.FREEWEBS.COM/STANFORDIGEM/ MEETING AGENDA: NOVEMBER 20, 2008 1. INTRODUCTION -IGEM MISSION & VISION (SUMMER AND BEYOND) -WHAT IS SYNTHETIC BIOLOGY? - IGEM 2008 JAMBOREE 2. TEAM STRUCTURE: -RESPONSIBILITIES & EXPECTATION -LEADERSHIP ROLES -TIME COMMITMENT 3. TIMELINE 4. APPLICATION & (TENTATIVE) INTERVIEW -CRITERIA 5. COURSEWORK -WINTER: INTRODUCTION TO SYNTHETIC BIOLOGY -SPRING: STUDENT-INITIATED COURSE & LAB TRAINING 6. FUNDING 7. Q&A IGEM 2008 JAMBOREE 1925 1200 825 84 77 24 22 21 MINUTES OF TALKS PARTICIPANTS ATTENDEES TEAMS PRESENTATIONS AWARDS WEEKS OF WORK COUNTRIES GRAND PRIZE WINNER: SLOVENIA 1ST RUNNER UP: FREIBURG 2ND RUNNER UP: CALTECH FINALIST: NYMU-TAIPEI UC BERKELEY HARVARD WINNING PROJECT ABSTRACTS: IMMUNOBRICKS SLOVENIA, HEALTH OR MEDICINE ALMOST HALF OF THE WORLD POPULATION IS INFECTED WITH BACTERIA HELICOBACTER PYLORI WHICH IS ALSO RECOGNIZED AS A TYPE I CARCINOGEN BY WHO. EFFECTIVE VACCINE AGAINST H.PYLORI IS NOT AVAILABLE, ALTHOUGH IT WOULD BE A DURABLE SOLUTION, PARTICULARLY IN A FORMULATION AFFORDABLE TO THE THIRD WORLD POPULATION. H.PYLORI EVADES THE IMMUNE SURVEILLANCE BY MODIFYING SEVERAL OF ITS COMPONENTS TO AVOID DETECTION BY SEVERAL TOLL-LIKE RECEPTORS. RECENT DISCOVERIES DEMONSTRATE THAT SYNERGY BETWEEN INNATE AND ADAPTIVE IMMUNE RESPONSE IS ESSENTIAL FOR AN EFFECTIVE VACCINE. W E USED PRINCIPLES OF SYNTHETIC BIOLOGY TO ASSEMBLE WELL DEFINED SYNTHETIC VACCINE, COMPOSED OF THE FUNCTIONAL “IMMUNOBRICKS”, WHICH COMBINE THE ACTIVATION OF INNATE IMMUNE RECEPTORS, APPROPRIATE CELLULAR LOCALIZATION FOR PROCESSING OF ANTIGENS AND ANTIGENIC SEGMENTS TO STIMULATE FORMATION OF ANTIBODIES AND CELLULAR ADAPTIVE RESPONSE. OUR ENGINEERED VACCINE WAS IMPLEMENTED IN THREE DIFFERENT TYPES OF VACCINES BASED ON RECOMBINANT PROTEIN, ENGINEERED BACTERIA AND GENETIC VACCINE. MODULAR SYNTHETIC TRANSMEMBRANE RECEPTOR SYSTEMS INTERFACED WITH NANO BREADBOARDS FREIBURG, MANUFACTURING SIGNALING THROUGH MEMBRANES IS A CHARACTERISTIC OF LIFE. TRANSMEMBRANE PROTEINS CONTROL PROLIFERATION, DIFFERENTIATION, AND CELLULAR RESPONSE AND ARE KEY FOR THE FORMATION OF MULTICELLULAR ORGANISMS. CONTROLLING SUCH PROTEINS ENABLES ONE TO MODIFY CELLULAR BEHAVIOR AND ULTIMATELY PROGRAM CELLS AT WILL. THE COMPLEX RULES FOR TRANSMEMBRANE SIGNALING OFTEN REQUIRE ENGAGEMENT OF SEVERAL PROTEINS IN A FINE-TUNED SPATIAL AND TEMPORAL MANNER. TO TAP INTO THE POSSIBILITIES OF TRANSMEMBRANE PROGRAMMING, THE FREIBURG 2008 IGEM TEAM PROVIDES AN EXTENSIBLE SYSTEM COMPRISING AN EXTERNAL FRAMEWORK WITH SPATIAL RESOLUTION, A CONCEPT FOR MODIFYING NATURAL RECEPTORS, AND A MODULAR SET OF FUSION-BIOBRICKS FOR THE CONSTRUCTION OF SYNTHETIC RECEPTORS. SPATIAL RESOLUTION IN NANOMETER SCALE IS PROVIDED BY DNA-ORIGAMI MODIFIED WITH DISTINCT PATTERNS AND COMBINATIONS OF LIGANDS. RECEPTORS ARE DECOUPLED FROM THEIR NATURAL LIGANDS BY FUSION WITH ARTIFICIAL BINDING DOMAINS. THE BIOBRICK COLLECTION CONTAINS SIGNAL SEQUENCES, BINDING DOMAINS, TRANSMEMBRANE DOMAINS, AND EFFECTOR DOMAINS FEATURING SPLIT ENZYMES AND SPLIT FLUORESCENT PROTEINS FOR IMMEDIATE READOUT. ENGINEERING MULTI-FUNCTIONAL PROBIOTIC BACTERIA CALTECH, HEALTH OR MEDICINE THE HUMAN GUT HOUSES A DIVERSE COLLECTION OF MICROORGANISMS, WITH IMPORTANT IMPLICATIONS FOR THE HEALTH AND WELFARE OF THE HOST. W E AIM TO ENGINEER A MEMBER OF THIS MICROBIAL COMMUNITY TO PROVIDE INNOVATIVE MEDICAL TREATMENTS. OUR WORK FOCUSES ON FOUR MAIN AREAS: (1) PATHOGEN DEFENSE, EITHER BY EXPRESSION OF PATHOGENSPECIFIC BACTERIOPHAGE OR BY TARGETED BURSTS OF REACTIVE OXYGEN SPECIES; (2) PREVENTION OF BIRTH DEFECTS BY FOLATE OVER-EXPRESSION AND DELIVERY; (3) TREATMENT OF LACTOSE INTOLERANCE, BY CLEAVING LACTOSE TO ALLOW FOR ABSORPTION IN THE LARGE INTESTINE; AND (4) REGULATION OF THESE THREE TREATMENT FUNCTIONS TO PRODUCE RENEWABLE SUBPOPULATIONS SPECIALIZED FOR EACH FUNCTION. OUR RESEARCH DEMONSTRATES THAT SYNTHETIC BIOLOGY TECHNIQUES CAN BE USED TO MODIFY NATURALLY OCCURRING MICROBIAL COMMUNITIES FOR APPLICATIONS IN BIOMEDICINE AND BIOTECHNOLOGY.